IFNA1 and severe acute respiratory syndrome: The previous study demonstrated that during SARS-CoV infection, a delay in type I interferon (IFN) expression (which is involved in the antiviral response) was associated with an inappropriate inflammatory response and lung pathology (Channappanavar et al., 2016), providing a favorable environment for viral replication and tissue injury.